SCG10/Stathmin-2 Antibody [F16M4]

Application: Reactivity: Rat, Human

Usage Information

Dilution
WB1:10000 - 1:50000 IP1:50 - 1:70

Application
WB, IP

Reactivity
Rat, Human

Source
Rabbit Monoclonal Antibody

Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage (from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years

Predicted MW
˜20 kDa

Datasheet & SDS

Biological Description

Specificity
SCG10/Stathmin-2 Antibody [F16M4] detects endogenous levels of total SCG10/Stathmin-2 protein.

Clone
F16M4

Synonym(s)
SCG10, SCGN10, STMN2, Stathmin-2, Superior cervical ganglion-10 protein, Protein SCG10

Background
SCG10, also known as stathmin-like 2 and encoded by STMN2, is a neuron-enriched member of the stathmin family that regulates microtubule dynamics during neuronal development, axon extension, and regeneration. The protein localizes predominantly to growth cones and distal neurites, where it modulates cytoskeletal organization through an N-terminal targeting region and a conserved stathmin-like domain that binds α/β-tubulin heterodimers to regulate microtubule assembly. SCG10 forms complexes with soluble tubulin to control polymer availability while selectively stabilizing microtubule plus ends by increasing growth persistence and suppressing catastrophe events, whereas minus ends undergo enhanced depolymerization that contributes to polarized microtubule remodeling required for neurite elongation and directional axon growth. Phosphorylation of SCG10 at multiple serine residues by JNK, ERK, and p38 MAPK pathways regulates its activity and turnover during neuronal stress and regeneration responses. Following peripheral nerve injury, JNK-dependent phosphorylation promotes Spy1-mediated ubiquitination and proteasomal degradation of SCG10, facilitating localized microtubule disassembly associated with axonal retraction and degeneration. SCG10 expression is highly elevated during embryonic neurogenesis and regenerative phases in sensory neurons, where it supports vesicular trafficking, mitochondrial distribution, and AMPA receptor transport along extending neurites. SCG10 associates with Golgi-derived vesicles and displays strong enrichment within growth cone membranes, enabling spatial regulation of microtubule remodeling in developing axons. Altered SCG10 expression and phosphorylation are linked to neurodegenerative conditions, including amyloid-β–associated pathology and tau-mediated cytoskeletal disruption, while loss of SCG10 impairs axonal regeneration after spinal cord injury.

Background

SCG10, also known as stathmin-like 2 and encoded by STMN2, is a neuron-enriched member of the stathmin family that regulates microtubule dynamics during neuronal development, axon extension, and regeneration. The protein localizes predominantly to growth cones and distal neurites, where it modulates cytoskeletal organization through an N-terminal targeting region and a conserved stathmin-like domain that binds α/β-tubulin heterodimers to regulate microtubule assembly. SCG10 forms complexes with soluble tubulin to control polymer availability while selectively stabilizing microtubule plus ends by increasing growth persistence and suppressing catastrophe events, whereas minus ends undergo enhanced depolymerization that contributes to polarized microtubule remodeling required for neurite elongation and directional axon growth. Phosphorylation of SCG10 at multiple serine residues by JNK, ERK, and p38 MAPK pathways regulates its activity and turnover during neuronal stress and regeneration responses. Following peripheral nerve injury, JNK-dependent phosphorylation promotes Spy1-mediated ubiquitination and proteasomal degradation of SCG10, facilitating localized microtubule disassembly associated with axonal retraction and degeneration. SCG10 expression is highly elevated during embryonic neurogenesis and regenerative phases in sensory neurons, where it supports vesicular trafficking, mitochondrial distribution, and AMPA receptor transport along extending neurites. SCG10 associates with Golgi-derived vesicles and displays strong enrichment within growth cone membranes, enabling spatial regulation of microtubule remodeling in developing axons. Altered SCG10 expression and phosphorylation are linked to neurodegenerative conditions, including amyloid-β–associated pathology and tau-mediated cytoskeletal disruption, while loss of SCG10 impairs axonal regeneration after spinal cord injury.

References
https://pubmed.ncbi.nlm.nih.gov/17311410/ https://pubmed.ncbi.nlm.nih.gov/27794104/

Reference Table for Selecting PVDF Membrane Pore Size Specifications

Protein Size (kDa)	PVDF Transfer Membrane Pore Size (μm)
< 10	0.22
10-20	0.22
20-30	0.45
30-45	0.45
45-70	0.45
80-100	0.45
100-140	0.45
> 140	0.45

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Protein Size (kDa)	Separating Gel Percentage
4-40	20%
12-45	15%
10-70	12.5%
15-100	10%
25-100	8%
60-210	5%